课题基金 / 基金详情

项目摘要

项目成果

Pedro L Vera的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our long-term goal is to discover novel therapeutic targets for pelvic pain. Pelvic pain, bladder pain specifically, is also the cardinal symptom of interstitial cystitis/bladder pain syndrome (IC/BPS) where most patients show no underlying bladder infection, pathology, or injury. The local and central mechanisms that mediate pelvic pain are not fully understood. There is an urgent need to correct this knowledge gap so as to develop effective novel therapeutic targets for chronic pelvic pain. Our overall objective in this application is to determine the mechanisms of MIF- mediated bladder hyperalgesia. Our central hypothesis is that MIF mediates bladder hyperalgesia through local (bladder) and central (spinal) mechanisms. We plan to test our central hypothesis by pursuing the following three specific aims: 1. Identify urothelial MIF receptors that mediate bladder hyperalgesia. Based on the published data referred to above, our working hypothesis is that released MIF acts at urothelial MIF receptors to elicit urothelial HMGB1 release and bladder hyperalgesia. 2. Identify downstream targets of MIF/HMGB1 that mediate bladder hyperalgesia. Our working hypothesis, based on our published and preliminary evidence, is that blocking downstream signaling pathways activated by MIF/HMGB1 will prevent bladder hyperalgesia. 3. Identify spinal mechanisms that mediate persistent bladder hyperalgesia. Based on our preliminary data, our working hypothesis is that increased production and release of spinal MIF activates increased release of spinal HMGB1 to maintain bladder pain. In order to accomplish these aims we will conduct studies using rodent models of bladder pain and in vitro studies using human urothelial cells. We will examine organ-level and spinal-level mechanisms of bladder pain while focusing on treating persistent bladder pain. We will also identify novel lumbosacral peptides/proteins associated with persistent bladder pain. Succesful completion of these studies is expected to have a positive impact because it is probable that the identified components of the mechanism will provide new peripheral and/or central targets for therapeutic interventions in conditions of bladder pain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macrophage Migration Inhibitory Factor mediates bladder pain
MIF: a pro-inflammatory cytokine as a novel target to reduce bladder inflammation
MIF: a pro-inflammatory cytokine as a novel target to reduce bladder inflammation
MIF: a pro-inflammatory cytokine as a novel target to reduce bladder inflammation
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: